REACTION BIOLOGY CORPORATION

Basic Information

ONE GREAT VALLEY PARKWAY
MALVERN, PA, 19355-1423

Company Profile

n/a

Additional Details

Field Value
DUNS: 611741799
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Epigenetics Probes: Production of histone modifying enzymes and identification o

    Amount: $287,650.00

    DESCRIPTION (provided by applicant): Production of histone modifying enzymes and identification of chemical probes for epigenetic discovery Genomic function is the major factor in the most common dise ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Chemoprotectants for Head-Neck Therapeutics

    Amount: $1,402,563.00

    DESCRIPTION (provided by applicant): Chemoprotectants for Head-Neck Therapeutics Oral mucositis occurs as a major dose-limiting and complicating side effect of chemotherapy, radiotherapy, or combined ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Methyltransferase Drug Discovery

    Amount: $1,203,226.00

    DESCRIPTION (provided by applicant): Chromatin assembly and structure is highly regulated during DNA replication, gene expression, and progression through the cell cycle. Dysfunctions of epigenetic fa ...

    SBIR Phase II 2010 Department of Health and Human Services
  4. Methyltransferase Drug Discovery

    Amount: $170,727.00

    DESCRIPTION (provided by applicant): Chromatin assembly and structure is highly regulated during DNA replication, gene expression, and progression through the cell cycle. Dysfunction of epigenetic fac ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. Chemoprotectants for Head-Neck Therapeutics

    Amount: $252,860.00

    DESCRIPTION (provided by applicant): Chemoprotectants for Head-Neck Therapeutics Oral mucositis occurs as a major dose-limiting and complicating side effect of chemotherapy, radiotherapy, or combined ...

    SBIR Phase I 2009 Department of Health and Human Services
  6. High throughput ELISA chip for drug toxicity screening

    Amount: $919,496.00

    DESCRIPTION (provided by applicant): High throughput ELISA chip for drug toxicity screening Summary Adverse drug metabolism, drug-drug interactions, and direct toxicity effects have caused numerous dr ...

    SBIR Phase II 2007 Department of Health and Human Services
  7. Kinome Drug Bioassay Platform

    Amount: $947,589.00

    DESCRIPTION (provided by applicant): Reaction Biology Corporation (RBC) has developed an extremely low cost nanoliter reaction microarray to serve various drug discovery needs for high throughput scre ...

    SBIR Phase II 2006 Department of Health and Human Services
  8. Enzyme Assay Chips for Apoptosis Discovery

    Amount: $750,869.00

    DESCRIPTION (provided by applicant): Reaction Biology Corporation has developed an extremely low cost nanoliter reaction microarrays to serve markets for ultra high throughput screening (uHTS) drug d ...

    SBIR Phase II 2005 Department of Health and Human Services
  9. Kinome Drug Bioassay Platform

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Protein kinases play pivotal roles in signal transactions, and dysfunction of them is a key factor for diseases like cancer, inflammation, diabetes etc. Kinome dr ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. High throughput ELISA chip for drug toxicity screening

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Adverse drug metabolism, drug-drug interactions, and toxicity effects cause numerous drug failures. High throughput screening (HTS) technologies to predict drug t ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government